Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shanghai Pharma Wants to Acquire US or European Pharma

publication date: Aug 16, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Pharmaceuticals is seeking to acquire a mid-sized US or European drugmaker, according to the company’s Chairman, Mingfang Lu. Shanghai Pharma wants to enlarge its supply of innovative drugs, he said, because the company sees patented products as a hedge against the price pressures affecting generic drugs in China. Lu summarized the situation by saying, "We hope to make structural improvements to our product portfolio by raising the proportion of innovative drugs, so as to better weather industry risks in the future.” More details....

Stock Symbol: (SHA: 601607)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...